GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Interest Cover History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Interest Cover(x) | 515.59 | 960.03 | 454.77 | 462.54 | 391.29 |
What is the latest Interest Cover ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Interest Cover |
|---|---|
| Mar2026 | 515.59 |
| Mar2025 | 960.03 |
| Mar2024 | 454.77 |
| Mar2023 | 462.54 |
| Mar2022 | 391.29 |
How is Interest Cover of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Interest Cover | % Change | |
|---|---|---|---|
| Mar2026 | 515.59 | -46.29 | |
| Mar2025 | 960.03 | 111.10 | |
| Mar2024 | 454.77 | -1.68 | |
| Mar2023 | 462.54 | 18.21 | |
| Mar2022 | 391.29 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Total Debt/Mcap |
Compare Interest Cover ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,771.0 Cr | -0.1% | -4.1% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.1% |
-4.1% |
-4.7% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses